Diametric Capital’s Alto Neuroscience ANRO Stock Holding History

Diametric Capital’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,315	Closed	-$232K	–	714
2026 Q1	$232K	Buy	+10,315	New	+$191K	0.06%	372
2024 Q2	–	Sell	-16,200	Closed	-$249K	–	482
2024 Q1	$249K	Buy	+16,200	New	+$254K	0.14%	205

Other funds holding ANRO

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SSC

Spruce Street Capital New York $510M AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Diametric Capital's ANRO Position: Q2 2026 in Review

Diametric Capital sold out of Alto Neuroscience (ANRO) in Q2 2026, closing a stake of 10,315 shares — an estimated $232K sold.

Diametric Capital first reported a position in ANRO in Q1 2024 and held it in 2 quarters. The position peaked at $249K in Q1 2024. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

Diametric Capital reported no remaining Alto Neuroscience position as of Q2 2026 after selling out during the quarter.
Diametric Capital sold 10,315 Alto Neuroscience shares in Q2 2026, an estimated $232K.
Diametric Capital first reported a position in Alto Neuroscience in Q1 2024 and held it in 2 quarters.
Diametric Capital's Alto Neuroscience position peaked at $249K in Q1 2024.
114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.